SEC FORM 4
$149,115.06
UNITED THERAPEUTICS Corp (UTHR)
Sale of 300 shares at $497.0502 per share.
Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S
Traded Sep 8, 2026 · Disclosed Sep 9, 2026
Source: SEC Form 4 · 0001106578-26-000137 · filed 2026-09-09 · View filing →